17th Annual Vascular Innovations Conference

Friday, April 14, 2023, 7:30 AM - 5:15 PM, Detroit Marriott - Troy, Troy , MI

The Vascular Innovations Conference provides physicians, vascular technologists, sonographers, nurses and physician assistants with a better understanding of vascular disease, technical advances, clinical applications and interpretation criteria for non-invasive vascular studies.

Save the date!
For questions about the  venue, agenda, etcetera, please email [email protected] 

1. Discuss the role that technological innovation is currently playing in the world of vascular ultrasound and medicine
2. Identify with common ergonomic issues and facilitate change in the workplace based on creative thinking and modern strategic approach
3. Discuss the utilization of Point of Care Ultrasound in the emergency department relative to vascular related issues
4. Recall current testing and treatment options for Non-thrombotic Iliac Vein Lesions and Pelvic Congestion
5. Explain the role of ultrasound in the diagnosis and management of vascular disease

 

Payment by credit card is preferred. To pay by check, email [email protected]

Registration Rates: 

 

Cancellations or refund requests must be received by March 31, 2023; a $40.00 cancellation processing fee will be assessed to all cancelled registrations. Cancellation or refund requests after March 31, 2023 will not be honored. To cancel a registration, please send an email to [email protected] with the name of the activity and “Cancellation” in the subject line.

AMA PRA Category 1 Credits™ (4.00 hours), AMA PRA Non-Physician (Attendance) (4.00 hours), Nursing CE (ANCC) (4.00 hours)

Credit information will be updated once agenda has been finalized.

Mitigation of Relevant Financial Relationships

Beaumont Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Exhibit at this Event